Viewing Study NCT02058160


Ignite Creation Date: 2025-12-25 @ 2:04 AM
Ignite Modification Date: 2026-01-07 @ 3:51 AM
Study NCT ID: NCT02058160
Status: COMPLETED
Last Update Posted: 2017-05-09
First Post: 2014-02-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes
Sponsor: Sanofi
Organization: